Elanco Animal Health Incorporated Common Stock vs Onto Innovation — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.92 (market cap $11.26B), while Onto Innovation trades at $294.53 (market cap $14.36B). The key difference: Onto Innovation is the larger of the two by market cap, and Onto Innovation is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and Onto Innovation for 6 Days on average.
| ELAN | ONTO | |
|---|---|---|
Market Cap | $11.26B | $14.36B |
Volume | 4,570,386 | 761,617 |
Sector | Health | Technology |
52-Week High | $26.84 | $378.45 |
52-Week Low | $19.76 | $121.34 |
Typical Hold Time | 1 Days | 6 Days |
Enterprise Value | $14.65B | $13.95B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →